Carotid Artery Stenosis Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023
- Published: Sep 2019
- Pages: 152
- SKU: IRTNTR32088
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The global carotid artery therapeutics market has the potential to grow by USD 333.77 million during 2019-2023. The growth momentum will accelerate throughout the forecast period, and the market will grow at a CAGR of more than 4%.
Growing awareness about carotid artery stenosis and the increasing demand for curative therapies are some of the major factors driving market growth. The US, the UK, and Germany are currently the major markets for carotid artery stenosis therapeutics.
Carotid Artery Stenosis Therapeutics Market Report - Key Insights
Scope of the Report
The report provides a detailed analysis of the market by product and geography. Also, the report analyzes the market’s competitive landscape and offers information on several market vendors.
Browse TOC and LoE with selected illustrations and example pages from carotid artery stenosis therapeutics market report
Market Segmentation
Carotid Artery Stenosis Therapeutics Market by Product
- Antithrombotics
- Antihyperlipidemics
- Antihypertensives
Carotid Artery Stenosis Therapeutics Market by Region
- Asia
- Europe
- North America
- ROW
Market Competitive Analysis
The carotid artery stenosis therapeutics market is fragmented, and the degree of fragmentation will increase during the forecast period. The rising prevalence of carotid artery stenosis has induced several vendors to enter the market with low-cost generics with assured safety and efficacy. Amgen Inc., AstraZeneca Plc, and Boehringer Ingelheim International GmbH are some of the major market participants. Though the accelerating growth momentum will offer immense growth opportunities, the availability of substitutes will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The report provides information on the production, sustainability, and prospects of several companies, including:
- Amgen Inc.
- AstraZeneca Plc
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
Carotid Artery Stenosis Therapeutics Market: Key Drivers and Trends
Several awareness programs are being conducted across the world to reduce the prevalence of carotid artery stenosis. Many governments and vendors are initiating multiple awareness and educational programs to increase the knowledge about carotid artery stenosis among people. For instance, the Circulation Foundation in the UK focuses on creating a vascular disease-free society by promoting awareness about vascular conditions and supporting vital researches. The organization’s awareness programs also raise funds, suggest preventing risk factors, and educate people about a healthy diet.
Similarly, the Stroke Awareness Foundation promotes awareness among communities and families about the devastating effects of strokes and carotid artery stenosis. Such awareness programs are increasing patient knowledge about the disease and are encouraging people with high-risk factors to prevent the disease. This is one of the key factors driving global carotid artery stenosis therapeutics market growth.
- Carotid artery stenosis therapeutics market trends such as increasing demand for curative therapies will also influence market growth.
- The high prevalence of carotid artery stenosis and the lack of approved drugs is providing significant growth opportunities for vendors.
- Side-effects associated with off-label drugs is increasing the demand for new curative therapies.
- Patients are shifting their preference toward alternatives such as endarterectomy, angioplasty, and stents for the treatment of carotid artery stenosis.
- However, high cost and risks associated with such procedures will drive patients to opt for safe curative therapies.
- During 2019-2023, the market will register a CAGR of more than 4%.
Carotid Artery Stenosis Therapeutics Market: Segmentation by Region
For more insights on the market share of various regions Request for a FREE sample now!
The rise in risk factors such as high cholesterol levels, smoking, alcohol consumption, high blood pressure, and diabetes have increased the prevalence of carotid artery stenosis in North America. The market in the region is witnessing a rise in the number of approved drugs for the treatment of carotid artery stenosis.
During the forecast period, over 38% of the overall market growth will originate from North America. However, market growth in the region will be slower than the growth of the market in Asia.
Carotid Artery Stenosis Therapeutics Market: Segmentation by Product
Request for a FREE sample and Get more information on the market contribution of various product segments
Antithrombotic drugs are generally used as the first-line option for the treatment of carotid artery stenosis. These drugs prevent the formation of fibrin meshes from fibrin protein and eliminate the trapping of blood cells in blood vessels by making the blood thin.
As a result, the carotid artery stenosis therapeutics market size will increase steadily in the antithrombotic drugs segment during the forecast period. However, market growth in antithrombotic segment will be slower than the growth of the market in antihyperlipidemic segment.
Carotid Artery Stenosis Therapeutics Market: Key Highlights of the Report
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the market during the next five years
- Precise estimation of the global carotid artery stenosis therapeutics market size and its contribution to the parent market
- Accurate carotid artery stenosis therapeutics market forecast on upcoming trends and changes in consumer behavior
- The growth of the carotid artery stenosis therapeutics industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of carotid artery stenosis therapeutics market companies
We can help! Our analysts can customize this report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Antithrombotics - Market size and forecast 2018-2023
- Antihyperlipidemics - Market size and forecast 2018-2023
- Antihypertensives - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Entry of generic drugs
- Technological advances in medical devices
- Increasing demand for curative therapies
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Amgen Inc.
- AstraZeneca Plc
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
